Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Neural correlates of heart rate variability during emotion
- R. Lane, K. McRae, E. Reiman, K. Chen, G. Ahern, J. Thayer
- Psychology, Medicine
- NeuroImage
- 1 January 2009
TLDR
Brain abnormalities in human obesity: A voxel-based morphometric study
- N. Pannacciulli, A. D. Parigi, K. Chen, D. S. Le, E. Reiman, P. A. Tataranni
- Psychology, Computer Science
- NeuroImage
- 15 July 2006
Obesity is accompanied by damage to several tissues. Overweight is a risk factor for Alzheimer's disease and other neurodegenerative disorders. Whether structural abnormalities associated with excess… Expand
Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation
TLDR
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
- E. Reiman, K. Chen, +5 authors J. Hardy
- Medicine
- Proceedings of the National Academy of Sciences…
- 19 December 2003
Fluorodeoxyglucose positron emission tomography (PET) studies have found that patients with Alzheimer's dementia (AD) have abnormally low rates of cerebral glucose metabolism in posterior cingulate,… Expand
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
- W. Jagust, D. Bandy, K. Chen, N. Foster, Alzheimer's Disease Neuroimaging Initiative
- Psychology, Medicine
- Alzheimer's & Dementia
- 1 May 2010
This is a progress report of the Alzheimer's Disease Neuroimaging Initiative (ADNI) positron emission tomography (PET) Core.
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
- A. Fleisher, K. Chen, +11 authors E. Reiman
- Medicine
- Archives of neurology
- 14 November 2011
OBJECTIVES
To characterize quantitative florbetapir F 18 (hereafter referred to as simply florbetapir) positron emission tomographic (PET) measurements of fibrillar β-amyloid (Aβ) burden in a large… Expand
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- E. Reiman, K. Chen, +14 authors R. Caselli
- Medicine
- Proceedings of the National Academy of Sciences
- 21 April 2009
Fibrillar amyloid-beta (Aβ) is found in the brains of many cognitively normal older people. Whether or not this reflects a predisposition to Alzheimer's disease (AD) is unknown. We used Pittsburgh… Expand
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
- G. Alexander, K. Chen, P. Pietrini, S. Rapoport, E. Reiman
- Psychology, Medicine
- The American journal of psychiatry
- 1 May 2002
OBJECTIVE
It is well established that regional cerebral metabolic rates for glucose assessed by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with Alzheimer's disease… Expand
Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease
- C. Stonnington, G. Tan, +6 authors R. Frackowiak
- Psychology, Medicine
- NeuroImage
- 1 February 2008
TLDR
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
- E. Reiman, Y. Quiroz, A. Fleisher, K. Chen, F. Lopera
- Psychology, Medicine
- The Lancet Neurology
- 1 December 2012
BACKGROUND
We have previously characterised functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's disease. To gain further knowledge on the preclinical phase of… Expand